• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Mol Immunol . Reduction and exhausted features of T lymphocytes under serological changes, and prognostic factors in COVID-19 progression

tetano

Editor, Senior Moderator
Mol Immunol


. 2021 Aug 6;138:121-127.
doi: 10.1016/j.molimm.2021.06.001. Online ahead of print.
Reduction and exhausted features of T lymphocytes under serological changes, and prognostic factors in COVID-19 progression


Ata Mahmoodpoor[SUP] 1 [/SUP], Maryam Hosseini[SUP] 2 [/SUP], Sadegh Soltani-Zangbar[SUP] 3 [/SUP], Sarvin Sanaie[SUP] 4 [/SUP], Leili Aghebati-Maleki[SUP] 5 [/SUP], Seyed Hadi Saghaleini[SUP] 6 [/SUP], Zohreh Ostadi[SUP] 6 [/SUP], Mahsa Hajivalili[SUP] 7 [/SUP], Zhinous Bayatmakoo[SUP] 8 [/SUP], Mostafa Haji-Fatahaliha[SUP] 9 [/SUP], Zohreh Babaloo[SUP] 9 [/SUP], Sima Shahmohammadi Farid[SUP] 9 [/SUP], Javad Ahmadian Heris[SUP] 10 [/SUP], Leila Roshangar[SUP] 11 [/SUP], Reza Rikhtegar[SUP] 12 [/SUP], Hossein Samadi Kafil[SUP] 13 [/SUP], Mehdi Yousefi[SUP] 14 [/SUP]



Affiliations

Abstract

Aims: Coronavirus disease 2019 (COVID-19) is a novel viral infection threatening worldwide health as currently there exists no effective treatment strategy and vaccination programs are not publicly available yet. T lymphocytes play an important role in antiviral defenses. However, T cell frequency and functionality may be affected during the disease.
Material and methods: Total blood samples were collected from patients with mild and severe COVID-19, and the total lymphocyte number, as well as CD4+ and CD8 + T cells were assessed using flowcytometry. Besides, the expression of exhausted T cell markers was evaluated. The levels of proinflammatory cytokines were also investigated in the serum of all patients using enzyme-linked immunesorbent assay (ELISA). Finally, the obtained results were analyzed along with laboratory serological reports.
Results: COVID-19 patients showed lymphopenia and reduced CD4+ and CD8 + T cells, as well as high percentage of PD-1 expression by T cells, especially in severe cases. Serum secretion of TNF-α, IL-1β, and IL-2 receptor (IL-2R) were remarkably increased in patients with severe symptoms, as compared with healthy controls. Moreover, high levels of triglyceride (TG) and low density lipoprotein cholesterol (LDL-C), were correlated with the severity of the disease.
Conclusion: Reduced number and function of T cells were observed in COVID-19 patients, especially in severe patients. Meanwhile, the secretion of proinflammatory cytokines was increased as the disease developed. High level of serum IL-2R was also considered as a sign of lymphopenia. Additionally, hypercholesterolemia and hyperlipidemia could be important prognostic factors in determining the severity of the infection.

Keywords: COVID-19; Cytokine; Exhaustion; Inflammation; T cells.
 
Back
Top Bottom